F8182
法罗培南钠 水合物
≥98% (HPLC)
别名:
(5R,6S,8R,2′R)-2-(2′-四氢呋喃基)-6-羟乙基青霉烯-3-羧酸钠盐, ALP 201, SUN 5555, SY 5555, Wy 49605, 呋罗培南, 法罗培南, 法罗培南钠片
登录 查看公司和协议定价
选择尺寸
关于此项目
经验公式（希尔记法）:
C12H14NNaO5S · xH2O
化学文摘社编号:
分子量:
307.30 (anhydrous basis)
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77
质量水平
方案
≥98% (HPLC)
表单
powder
旋光性
[α]/D +120 to +130°, c = 1.0 in water
储存条件
desiccated
颜色
white to light brown
溶解性
H2O: ≥20 mg/mL
创始人
Daiichi-Sankyo
储存温度
−20°C
SMILES字符串
O.[Na+].C[C@@H](O)C1C2SC(C3CCCO3)=C(N2C1=O)C([O-])=O
InChI
1S/C12H15NO5S.Na.H2O/c1-5(14)7-10(15)13-8(12(16)17)9(19-11(7)13)6-3-2-4-18-6;;/h5-7,11,14H,2-4H2,1H3,(H,16,17);;1H2/q;+1;/p-1/t5-,6-,7+,11-;;/m1../s1
InChI key
FHSVCMPZCIOKGW-VIDQLUEFSA-M
一般描述
法罗培南钠水合物属于口服处方的青霉类抗生素。具有头孢菌素抗性的肠杆菌科细菌感染易受法罗培南的影响。法罗培南可能是治疗由广谱β-内酰胺酶（ESBL）产生细菌引起的尿路感染的一种有效的抗生素。
生化/生理作用
属于培南类的光谱β-内酰胺抗生素；β-内酰胺酶稳定。
法罗培南钠是一种超广谱、耐受β-内酰胺酶的β-内酰胺抗生素，对革兰氏阳性和革兰氏阴性细菌均具有活性。
特点和优势
该化合物由Daiichi-Sankyo开发。要浏览其他药物开发化合物和批准的药物/候选药物列表，单击此处。
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
此项目有
T Sekiguchi et al.
The Japanese journal of antibiotics, 48(2), 220-228 (1995-02-01)
SY5555 in dry syrup (powder which is dissolved before use) or tablet form was given orally to 21 children with acute bacterial infections including 4 with acute pharyngitis, 5 with acute tonsillitis, 7 with acute bronchitis, 2 with acute gastroenteritis
In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.
E Inoue et al.
Antimicrobial agents and chemotherapy, 38(9), 1974-1979 (1994-09-01)
The antibacterial activity of SY5555, a new oral penem antibiotic, was compared with those of cefaclor, cefixime, and cefteram. SY5555 was more active than the comparison agents against methicillin-susceptible Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Enterococcus faecalis, Citrobacter freundii, Enterobacter
Novel carbon-carbon bond cleavage reaction of penem antibiotic by class C beta-lactamases.
R Tanaka et al.
The Journal of antibiotics, 47(8), 945-948 (1994-08-01)
J M Woodcock et al.
The Journal of antimicrobial chemotherapy, 39(1), 35-43 (1997-01-01)
The in-vitro activity of faropenem, a novel oral penem, was studied in comparison with other beta-lactam antimicrobials against 711 recent clinical isolates including Gram-negative, Gram-positive and anaerobic bacteria. MIC data showed that faropenem was active against most members of the
S K Spangler et al.
Antimicrobial agents and chemotherapy, 38(12), 2902-2904 (1994-12-01)
In vitro susceptibility of 185 penicillin-susceptible and -resistant pneumococci to WY-49605, a new oral penem, was compared with susceptibility to penicillin G, amoxicillin with and without clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. WY-49605 yielded MICs for 50 and 90%
商品
Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持